查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362910

分叉病变市场规模、份额、趋势分析报告：按用途、区域、细分趋势，2023-2030

Bifurcation Lesions Market Size, Share & Trends Analysis Report By Application (Coronary Vascular, Peripheral Vascular), By Region (North America, Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

分叉病变市场成长与趋势：

根据Grand View Research, Inc.最新报告，到2030年，全球分叉病变市场规模预计将达到34.8亿美元，预测期内年复合成长率为5.9%。

政府对技术开发和报销的支持措施可能会在预测期内推动市场。

不断增长的老年人口和不健康的生活方式是心血管疾病发病率不断增加的原因。此外，创新设备的核准和商业化的增加以及未来年度用于治疗分叉病变的新设备的预期进入也可能推动市场。

此外，负担能力的提高、微创手术需求的增加以及医疗旅游的增加等要素也推动了全球对分叉病变手术的需求。根据各种研究，针对冠状动脉分叉病变的手术约占所有经皮冠状动脉介入治疗的20%。

分叉病变市场报告亮点

  • 分叉病变设备商业化的增加以及产业参与者对研发的投资是推动市场上升的要素，预计2023年至2030年的年复合成长率约为5.9%。
  • 由于心臟内存在复杂的血管网络、设备可用性的增加以及人们对分叉病变手术干预的认识不断增强，冠状血管部分在 2022 年将占据最大的市场占有率。
  • 由于产业参与者增加了开发週边应用设备的投资，以及有助于准确检测斑块的诊断技术的进步，末稍血管领域可能在未来年度呈现良好的成长。
  • 按地区划分，2022年北美占据分叉病变市场最大份额。由于药物释放型支架的需求不断增加、分叉病变装置的商业化以及主要市场参与者在当地的存在，预计它将保持其主导地位。
  • 由于医疗基础设施、医疗旅游业的改善以及该地区市场参与者的投资增加，亚太地区预计将在未来年度经历最快的成长。
  • Tryton Medical, Inc.开发了球囊扩张式Tryton侧支支架，可放置在侧支动脉中用于治疗分叉病变。该支架销往美国、欧洲和中东/非洲。

目录

第1章调查方法与范围

第2章执行摘要

第3章分叉病变市场变数、趋势和范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 分岔病变市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章分叉病变：用途估计及趋势分析

  • 分叉病变市场：要点
  • 分叉病变市场：2022 年和 2030 年趋势和市场占有率分析
  • 末稍血管
  • 冠状血管

第5章分叉病变市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的分叉病变市场：市场要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第6章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Boston Scientific Corporation
    • Abbott
    • Cardinal Health
    • Medtronic
    • CR Bard, Inc.
    • Johnson and Johnson Services, Inc.
    • Spectranetics
    • Terumo Medical Corporation
    • Tryton Medical Inc.
Product Code: GVR-1-68038-534-2

Bifurcation Lesions Market Growth & Trends:

The global bifurcation lesions market size is expected to reach USD 3.48 billion by 2030, registering a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc.. Technological developments and supportive government initiatives for reimbursement are likely to drive the market during the forecast period.

The increasing geriatric population and unhealthy lifestyle are responsible for growth in the incidence of cardiovascular disorders. Furthermore, an increase in approval & commercialization of innovative devices and the expected entry of new devices for the treatment of bifurcation lesions in the coming years are likely to drive the market.

In addition, factors such as rising affordability, increase in demand for minimally invasive procedures, and growing medical tourism are also boosting demand for bifurcation lesions procedures across the globe. According to various studies, procedures for coronary bifurcation lesions comprise approximately 20% of total percutaneous coronary interventions.

Bifurcation Lesions Market Report Highlights:

  • Increase in the commercialization of devices for bifurcation lesions and investments by industry players for R&D are the factors expected to boost the market, resulting in an anticipated CAGR of around 5.9% from 2023 to 2030
  • The coronary vascular segment accounted for the maximum share of the market in 2022 due to the presence of complex vascular network in heart, increased availability of devices, and rise in awareness regarding surgical interventions for bifurcation lesions.
  • The peripheral vascular segment is likely to witness lucrative growth in the coming years due to an increase in investments by industry players for the development of devices for peripheral application and advancements in diagnostics facilitating accurate detection of plaque.
  • Geographically, North America held the largest share of the bifurcation lesions market in 2022. It is anticipated to maintain its dominance in the coming years due to increasing demand for drug-eluting stents, commercialization of devices for bifurcation lesions, and the local presence of major market players.
  • The Asia Pacific is expected to observe the fastest growth over the next decade owing to improvement in healthcare infrastructure, medical tourism, and a rise in investments by market players in the region.
  • Some of the key players in the market are Abbott; Boston Scientific Corporation; Cardinal Health; Medtronic; Johnson & Johnson Services, Inc.; C. R. Bard, Inc.; Spectranetics; and Terumo Medical Corporation. Tryton Medical, Inc. developed the Tryton Side Branch Stent with a balloon-expandable, single-wire stent delivery system that can be deployed in the side branch artery for treatment of bifurcation lesions. The device is available in the U.S. and Europe as well as Middle East & Africa.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Bifurcation Lesions Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Bifurcation Lesions Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Bifurcation Lesions: Application Estimates & Trend Analysis

  • 4.1. Bifurcation Lesions Market: Key Takeaways
  • 4.2. Bifurcation Lesions Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Peripheral Vascular
    • 4.3.1. Peripheral vascular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Coronary Vascular
    • 4.4.1. Coronary vascular market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Bifurcation Lesions Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Bifurcation Lesions Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Boston Scientific Corporation
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Abbott
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Cardinal Health
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Medtronic
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. C. R. Bard, Inc.
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Johnson and Johnson Services, Inc.
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Spectranetics
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Terumo Medical Corporation
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Tryton Medical Inc.
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • 1. List of Abbreviations
  • 2. North America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 3. North America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 4. U.S. bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 5. Canada bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 6. Europe bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 7. Europe bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 8. Germany bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 9. UK bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 10. France bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 11. Italy bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 12. Spain bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 13. Sweden bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 14. Norway bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 15. Denmark bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 16. Asia Pacific bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 17. Asia Pacific bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 18. China bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 19. Japan bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 20. India bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 21. Australia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 22. Thailand bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 23. South Korea bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 24. Latin America bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 25. Latin America bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 26. Brazil bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 27. Mexico bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 28. Argentina bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 29. Middle East and Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 30. Middle East and Africa bifurcation lesions market, by region, 2018 - 2030 (USD Million)
  • 31. South Africa bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 32. Saudi Arabia bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 33. UAE bifurcation lesions market, by application, 2018 - 2030 (USD Million)
  • 34. Kuwait bifurcation lesions market, by application, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. Value-chain-based sizing & forecasting

6. QFD modeling for market share assessment

7. Market formulation & validation

8. Bifurcation lesions: Market outlook

9. Bifurcation lesions: Competitive insights

10. Parent market outlook

11. Related/ancillary market outlook

12. Penetration and growth prospect mapping

13. Industry value chain analysis

14. Bifurcation lesions market driver impact

15. Bifurcation lesions market restraint impact

16. Bifurcation lesions market strategic initiatives analysis

17. Bifurcation lesions market: Application movement analysis

18. Bifurcation lesions market: Application outlook and key takeaways

19. Peripheral vascular market estimates and forecasts, 2018 - 2030 (USD Million)

20. Coronary vascular market estimates and forecasts, 2018 - 2030 (USD Million)

21. Global bifurcation lesions market: Regional movement analysis

22. Global bifurcation lesions market: Regional outlook and key takeaways

23. North America market estimates and forecasts, 2018 - 2030 (USD Million)

24. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)

25. Canada market estimates and forecasts, 2018 - 2030 (USD Million)

26. Europe market estimates and forecasts, 2018 - 2030 (USD Million)

27. UK market estimates and forecasts, 2018 - 2030 (USD Million)

28. Germany market estimates and forecasts, 2018 - 2030 (USD Million)

29. France market estimates and forecasts, 2018 - 2030 (USD Million)

30. Italy market estimates and forecasts, 2018 - 2030 (USD Million)

31. Spain market estimates and forecasts, 2018 - 2030 (USD Million)

32. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)

33. Norway market estimates and forecasts, 2018 - 2030 (USD Million)

34. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)

35. Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)

36. Japan market estimates and forecasts, 2018 - 2030 (USD Million)

37. China market estimates and forecasts, 2018 - 2030 (USD Million)

38. India market estimates and forecasts, 2018 - 2030 (USD Million)

39. Australia market estimates and forecasts, 2018 - 2030 (USD Million)

40. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)

41. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)

42. Latin America market estimates and forecasts, 2018 - 2030 (USD Million)

43. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)

44. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)

45. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)

46. Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)

47. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)

48. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)

49. UAE market estimates and forecasts, 2018 - 2030 (USD Million)

50. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)